Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation

Ann Intern Med. 2021 Oct;174(10):1489. doi: 10.7326/L21-0563.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Dabigatran
  • Humans
  • Warfarin* / adverse effects

Substances

  • Anticoagulants
  • Warfarin
  • Dabigatran